Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL B BRENNER

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1699732909
CMS profile
76922
Location
BOSTON, MA

General Payments · PY2018–2024

$122,744.97

  • Reported across 81 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$55,458.81

30 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $18,164.38 14
GlaxoSmithKline, LLC. $16,602.66 8
Moderna TX, Inc. $8,926.00 2
Janssen Research & Development, LLC $4,860.00 1
Otsuka Pharmaceutical Co., Ltd. $2,500.00 1
Alexion Pharmaceuticals, Inc. $1,800.00 1
UCB SA $1,500.00 1
PFIZER INC. $1,105.77 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $7,772.64 3
PY2019 $25,224.28 18
PY2020 $9,558.07 5
PY2021 $9,710.00 3
PY2022 $275.47 1
PY2023 $14,745.70 21
PY2024 $55,458.81 30

Payment records · PY2024 (30)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $7,200.00 01/18/2024 Consulting Fee Undisputed 01/23/2026 1103132369 CMS
ABBVIE INC. $55.04 01/18/2024 Food and Beverage Undisputed 01/23/2026 1103366465 CMS
ABBVIE INC. $113.03 01/18/2024 Travel and Lodging Undisputed 01/23/2026 1104178702 CMS
ABBVIE INC. $154.49 12/04/2024 Travel and Lodging Undisputed 01/23/2026 1104178704 CMS
ABBVIE INC. $232.45 12/04/2024 Travel and Lodging Undisputed 01/23/2026 1104178706 CMS
ABBVIE INC. $14.99 12/05/2024 Food and Beverage Undisputed 01/23/2026 1103366467 CMS
ABBVIE INC. $26.43 12/05/2024 Food and Beverage Undisputed 01/23/2026 1103366469 CMS
ABBVIE INC. $14.99 12/05/2024 Food and Beverage Undisputed 01/23/2026 1103366471 CMS
ABBVIE INC. $45.43 12/05/2024 Food and Beverage Undisputed 01/23/2026 1103366473 CMS
ABBVIE INC. $449.47 12/05/2024 Travel and Lodging Undisputed 01/23/2026 1104178708 CMS
ABBVIE INC. $8,125.00 12/18/2024 Consulting Fee Undisputed 01/23/2026 1103132371 CMS
ABBVIE INC. $26.06 12/18/2024 Food and Beverage Undisputed 01/23/2026 1103366475 CMS
ABBVIE INC. $82.00 12/18/2024 Travel and Lodging Undisputed 01/23/2026 1104178710 CMS
ABBVIE INC. $1,625.00 12/18/2024 Travel and Lodging Undisputed 01/23/2026 1104178712 CMS
Alexion Pharmaceuticals, Inc. $1,800.00 02/22/2024 Consulting Fee Undisputed 01/23/2026 1093888144 CMS
GlaxoSmithKline, LLC. $8,050.00 01/21/2024 Consulting Fee Undisputed 01/23/2026 1116678995 CMS
GlaxoSmithKline, LLC. $382.30 05/22/2024 Travel and Lodging Undisputed 01/23/2026 1116153418 CMS
GlaxoSmithKline, LLC. $563.92 05/22/2024 Travel and Lodging Undisputed 01/23/2026 1116334053 CMS
GlaxoSmithKline, LLC. $32.60 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116376638 CMS
GlaxoSmithKline, LLC. $90.24 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116448845 CMS
GlaxoSmithKline, LLC. $32.60 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116660579 CMS
GlaxoSmithKline, LLC. $7,360.00 12/24/2024 Consulting Fee Undisputed 01/23/2026 1116322813 CMS
GlaxoSmithKline, LLC. $91.00 12/24/2024 Travel and Lodging Undisputed 01/23/2026 1116380198 CMS
Janssen Research & Development, LLC $4,860.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1077589833 CMS
ModernaTX, Inc. $4,560.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1152559012 CMS
ModernaTX, Inc. $4,366.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1152559014 CMS
Otsuka Pharmaceutical Co., Ltd. $2,500.00 05/16/2024 Consulting Fee Undisputed 01/23/2026 1093180320 CMS
PFIZER INC. $1,050.00 02/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131534752 CMS
PFIZER INC. $55.77 02/23/2024 Travel and Lodging Undisputed 01/23/2026 1131539270 CMS
UCB SA $1,500.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 1113951529 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.